Advances in the management of giant cell arteritis–aortitis: biologic therapies and beyond - a narrative review

Key Points

• The aim is to evaluate management strategies for giant cell arteritis and aortitis, focusing on biologic therapies.
• Reviewed existing literature on treatment strategies and treatment outcomes.
• Analyzed pharmacological options including glucocorticoids and tocilizumab.
• Discussed imaging techniques to assess remission.
• Recommends a treat-to-target strategy for achieving clinical remission.
• Highlights the importance of glucocorticoids as the main treatment.
• Suggests that tocilizumab and new targeted therapies may enhance long-term outcomes.